Research Groups and R&D Platforms: In Vitro Diagnostics

Research Group:
Bacterial infections: translational genomics, immunity and prevention

Qiushui He
Qiushui.He[at]utu.fi

Institute of Biomedicine,
University of Turku

Qiushui He

Bacterial infections: translational genomics, immunity and prevention

Allergy, Antibodies, Assay development, Bacteriology, Biomedicine, Epidemiology, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Nucleic acids

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Institute of Biomedicine,
University of Turku

Sirpa Jalkanen

Cell Trafficking in Cancer and Inflammation

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery

Research Group:
Digital DNA diagnostics for detection of antimicrobial resistant pathogens

Ari Lehmusvuori
artule[at]utu.fi

Department of Biochemistry,
University of Turku

Ari Lehmusvuori

Antibioottiresistenttien bakteerien nopea detektio digitaalisella DNA-sensoritekniikalla

Assay development, Biochemistry, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, Genetics, Genomics, In Vitro Diagnostics, Infection, Molecular diagnostics, Molecular modelling, Nucleic acids

Research Group:
The in vitro/in vivo applications of hot electrons in clinical research and health care

Heikki Peuravuori
heipeu[at]utu.fi

Institute of Biomedicine,
University of Turku

Heikki Peuravuori

Antibacterial, Antibodies, Assay development, Bacteriology, Biochemistry, Biomarker, Biomedicine, Biotechnology, Chemical Physics, Clinical Chemistry, Electron microscopy, Fluorescence spectroscopy, Imaging software, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Medicinal chemistry, Point of care

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Clinical Research Services Turku

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery

Research Group:
Genetic predisposition to cancer

Johanna Schleutker
Johanna.Schleutker[at]utu.fi

Institute of Biomedicine,
University of Turku

Johanna Schleutker

Genetic Predisposition to Prostate Cancer

Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening